XML 68 R46.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Note 19 - Income Tax | 12 Months Ended
--- | ---
Dec. 31, 2023
Notes to Financial Statements |
Income Tax Disclosure [Text Block] | NOTE 19: INCOME TAX The total provision for income taxes differs from the amount which would be computed by applying the US income tax rate to loss before income taxes. The reasons for these differences are as follows:
|  | December 31 |
|  | 2023 |  |  | 2022 |
Statutory income tax rate |  |  | 27.60 | % |  |  | 28.51 | %
Statutory income tax recovery |  | $ | (718 | ) |  | $ | (1,113 | )
Increase (decrease) in income taxes |  |  |  |  |  |  |  |
Non-deductible option expenses |  |  | 135 |  |  |  | 19 |
Taxable capital gain on sale of investment and equipment |  |  | - |  |  |  | - |
Difference in foreign tax rates |  |  | 30 |  |  |  | 200 |
US state tax |  |  | 1 |  |  |  | (1 | )
Change in valuation allowance |  |  | 553 |  |  |  | 895 |
Income tax expense (recovery) |  | $ | 1 |  |  | $ | - |
The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of assets and liabilities and certain carry-forward balances. The primary components of the deferred tax assets and liabilities are as follows, for the periods indicated below:
|  | December |
|  | 2023 |  |  | 2022 |
|  | $ |  |  | $ |
Deferred tax assets |  |  |  |  |  |  |  |
Non-capital loss carry-forwards from Canada |  |  | - |  |  |  | 1 |
Non-capital loss carry-forwards from US |  |  | 1,418 |  |  |  | 1,576 |
Non-capital loss carry-forwards from Israel |  |  | 15,449 |  |  |  | 17,479 |
Stock option |  |  | 95 |  |  |  | 17 |
R&D expenditures |  |  | 236 |  |  |  | 424 |
Reserves and others |  |  | 127 |  |  |  | - |
|  |  | 17,325 |  |  |  | 19,497 |
Valuation Allowances for deferred tax assets |  |  | (17,325 | ) |  |  | (19,497 | )
Net deferred tax assets |  |  | - |  |  |  | - |
The net deferred tax assets have been offset by a valuation allowance because it is not more likely than not the Company will realize the benefit of these deferred tax assets. The Company did not recognize any tax benefits as of December 31, 2023 and December 31, 2022. At December 31, 2023, the Company's Canadian, US, and Israeli non-capital income tax losses, the benefit of which has not been recognized on the consolidated financial statements, expire as follows:
|  | Canada |  |  | US |  |  | Israel |
2034 |  | $ | - |  |  | $ | 501 |  |  | $ | - |
2035 |  |  | - |  |  |  | 1,767 |  |  |  | - |
2036 |  |  | - |  |  |  | 2,872 |  |  |  | - |
2037 |  |  | - |  |  |  | - |  |  |  | - |
2038 |  |  | - |  |  |  | - |  |  |  | - |
2039 |  |  | - |  |  |  | - |  |  |  | - |
2040 |  |  | - |  |  |  | - |  |  |  | - |
2041 |  |  | - |  |  |  | - |  |  |  | - |
2042 |  |  | 2 |  |  |  | - |  |  |  | - |
Indefinite |  |  | - |  |  |  | 1,293 |  |  |  | 67,170 |
|  | $ | 2 |  |  | $ | 6,433 |  |  | $ | 67,170 |
At December 31, 2023, the Company had a cumulative carry-forward pool of Israeli Research and Development expenditures in the amount of $889 (2022: $1,823) which will be amortized within the next three years. The Company files unconsolidated federal income tax returns domestically and in foreign jurisdictions. The Company has open tax years from 2018 to 2023 with tax jurisdictions including Canada, U.S, and Israel. These open years contain certain matters that could be subject to differing interpretations of applicable tax laws and regulations, as they relate to amount, timing, or inclusion of revenues and expenses.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income tax. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/740/tableOfContent Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration